ALNY - Alnylam Pharmaceuticals Inc Earnings

Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

Peers: ARWR IONS BBIO REGN ARGX VRTX WVE BMRN NTLA AMGN

| Held by: VTI VO QQQ VUG VXF VOT IBB CGGR IWP TCAF

Scroll to Statements

Index	NDX
Market Cap	30.49B
Enterprise Value	30.17B
Income	807.99M
Sales	4.80B
Book/sh	10.13
Cash/sh	24.72
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2500
IPO	May 28, 2004

P/E	38.47
Forward P/E	23.64
PEG	0.33
P/S	6.35
P/B	22.50
P/C	9.22
P/FCF	38.40
EV/EBITDA	28.61
EV/Sales	6.28
Quick Ratio	2.99
Current Ratio	3.05
Debt/Eq	2.21
LT Debt/Eq	1.98
Option/Short	Yes / Yes

EPS (ttm)	5.92
EPS next Y	9.64
EPS next Q	1.66
EPS this Y	178.58%
EPS next Y	48.46%
EPS next 5Y	72.24%
EPS past 3/5Y	- -
Sales past 3/5Y	52.98% 49.77%
EPS Y/Y TTM	347.31%
Sales Y/Y TTM	95.14%
EPS Q/Q	337.86%
Sales Q/Q	66.86%
Earnings	Oct 29 BMO
EPS/Sales Surpr.	-25.78% -2.36%

Insider Own	0.32%
Insider Trans	-1.29%
Inst Own	100.62%
Inst Trans	-0.99%
ROA	15.96%
ROE	100.70%
ROIC	20.01%
Gross Margin	79.65%
Oper. Margin	20.81%
Profit Margin	16.82%
SMA20	-1.32%
SMA50	-4.72%
SMA200	-21.41%
Trades

Shs Outstand	133.73M
Shs Float	133.38M
Short Float	5.78%
Short Ratio	4.44
Short Interest	7.71M
52W High	485.36 -53.06%
52W Low	197.81 15.18%
Volatility	2.93% 3.71%
ATR (14)	8.15
RSI (14)	44.64
Beta	0.37
Rel Volume	0.02
Avg Volume	1.74M
Volume	1,694

Perf Week	-1.72%
Perf Month	-8.71%
Perf Quarter	-18.16%
Perf Half Y	-25.43%
Perf YTD	-42.70%
Perf Year	-50.90%
Perf 3Y	40.64%
Perf 5Y	14.72%
Perf 10Y	521.24%
Recom	1.61
Target Price	370.42
Prev Close	227.28
Price	227.84
Change %	0.25%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)